Inhalants Flashcards

1
Q

Inhalants

A

aerosols, solvents, glues

gases and liquids inhaled directly or by accessory (rag, bag)
mixtures of lipophilic chemicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

most common chemical mixtures

A

toluene
benzene
acetone

found across all forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

use as anesthetics

A

N2O activates D2-like signaling in the nucleus accumbens → disrupts nociception

amyl nitrate releases NO in the blood → potent vasodilator = treatment of heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

administration

A

inhalation:
huffing, sniffing, bagging → inhalation of vapours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

absorption

A

rapid
inhalation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

distribution

A

rapid and wide
small lipophilic molecules
distributes greatest concentration to fatty tissues = brain (myelin - lipids)
[blood] = 150-200 µM
[brain] = 100-900 µM

fast onset: ~10 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

metabolism

A

toluene is metabolized in the liver by CYP2E1
toluene → 80% benzoic acid → hippuric acid

duration: 15-120 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

excretion

A

kidneys
breath → gaseous nature of inhalants; volatile substances are exhaled = fast uptake and excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

hippuric acid

A

metabolite of toluene
can reduce blood pH at high doses = acidosis
→ can’t transport oxygen; tissues become hypoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

acute effects

A

biphasic effect

depressant drugs - slurred speech, inebriation

at low doses: disinhibition of motor circuits
at high doses: hallucination, anesthesia, coma, death (depression of critical structures for autonomic functions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

biphasic effect

A
  1. quick high (15-45 min) = euphoria, disinhibition, dizziness, light-headedness
  2. depression (1-2 hrs) = drowsiness, disorientation, headache
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

disinhibition of motor circuits

A

at low doses
depressed modulation of cerebellum
ex. can’t walk in a straight line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

physiological mechanisms of toluene

A

reward and euphoria via VTA → NAc reward pathway
elevated striatal dopamine levels

motor effects caused by effects on GABA in the caudate putamen
- basal ganglia → descending motor circuits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

cellular mechanisms of toluene

A
  1. dopamine-mediated reinforcement
  2. potentiates GABA and glycine (inhibitory)
  3. inhibits NMDA-Glu receptors and nAChRs (excitatory)

sum of actions on ionotropic channels, Ca2+ signaling, G-proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dopamine-mediated reinforcement

A

direct activation of VTA dopaminergic projections to the NAc to enhance dopamine release
stimulatory effect on DA neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

electrophysiology

A

stimulate neuron channels and measure current conducted through single channel

17
Q

Beckstead et al. 2000

A

use of heterologous culture: express GABA channels from humans in frog eggs

amount of current at a time through a single channel
measure deflections of current through GABA/glycine channels in presence + absence of toluene, trichloroethylene, and trichloroethane

18
Q

potentiation of GABA

A

toluene = more potently potentiating GABA channel current
>2x current passing through channel compared to only GABA

19
Q

potentiation of glycine

A

expression of channels in presence of glycine →
increase of negative current

Cl- channel
→ potentiate inhibitory current = hyperpolarization of cells → decreased electrical activity

20
Q

Cruz et al. 1998

A

recombinant NMDA receptors expressed in frog oocytes = heterologous culture
measure of current: control = NMDA + glycine (before drug); with toluene; washout recovery (after drug is gone)

21
Q

inhibition of NMDA 2B-containing receptors

A

NMDA receptors have different sub-type compositions - depending on brain region
all subunits show decreased deflection when toluene is added = less current through channels (inhibited)

2B-containing channels showed the least deflection in presence of toluene = most sensitive to toluene

dose response curve: 2B shows shift to left (steeper curve) = lower doses required to inhibit current through 2B-containing receptors

22
Q

inhibition of nAChR B2-containing receptors

A

dose dependent inhibition of β2 containing nAChRs
α4β2 subunit exhibits highest sensitivity to toluene-mediated inhibition

23
Q

nACh receptors in hippocampus

A

cultured hippocampal neurons are insensitive to acetylcholine in presence of toluene
still some firing seen but drastically reduced by toluene

24
Q

acute adverse effects

A

sensitize heart to epinephrine = sympathetic responses
cardiac dysrhythmias
mechanical asphyxiation
aspiration of vomit
trauma
unconsciousness, respiratory suppression, coma

25
Q

cardiac dysrhythmias

A

inhibited inactivation of voltage-gated Na+ and Ca2+ channels
QT interval (ventricular depolarization to complete repolarization) is prolonged = >480 ms
causes symptoms: tightness in chest, shortness of breath, palpitations

chemicals in nerve membrane alter kinetics of channel activation → don’t inactivate (can’t be turned off)
→ disregulation of action potentials

26
Q

aerosol-evoked cardiac arrest

A

chemicals at high pressure are cold → rapid chilling of epithelium in the larynx → mucosal edema and laryngospasm cause hypoxia (low O2 levels in throat and tissues) → irritate descending vagal (C10) nerve (controls heart tone)
→ elevated ACh release onto heart → bradycardia (slowed heart rate) and cardiac arrest

(blood is no longer being pumped because the heart is out of regulation)

27
Q

sudden sniffing death syndrome

A

encapsulates acute adverse effects into one syndrome
1/5 new users = 20% at risk of sudden death

28
Q

tolerance

A

may occur to euphoric effects of some inhalants

potentiation of receptor = cell decreases expression (restore normal)
increased NMDA receptor responses + decreased GABA receptor responses = hyperexcitable state in withdrawal

29
Q

withdrawal

A

mild symptoms; depends on frequency, dose (how much receptor levels change)
slow to develop
nausea, tremors, irritability, anxiety, sleep disturbances

30
Q

dependence

A

no psychological/physical
mild (usually only used for 1-2 years)
long term use → excitotoxicity/demyelination
increased NMDAR levels = too much Ca2+ release → cellular signaling

seen in rats: conditioned place preference by self-administration of toluene

31
Q

mechanisms → long term abuse

A

inhibitory:
NMDA/AChR inhibition
GABA/glycine potentiation

neuroadaptation - altered sensitivity of channels to drug binding (less prevalence of NMDA 2B and nAChR B2 subunits = shift away from sensitivity)

ACh attenuation initially → excitotoxicity (long term consequence = brain damage)

32
Q

hippocampal adaptations

A

Acetylcholine

structural changes as quickly as 4 days
- NMDA receptor subunit composition changes = increased 2B proteins (receptor subunits) seen in Western blot
- on medium spiny neuron membranes, receptor staining increases

33
Q

neuronal death in hippocampus

A

CA1 and CA3 regions after 40 day 200ppm toluene cycle
= memory loss

34
Q

long term risks

A

memory, cognitive, behavioural impairment
in youth, affects development of critical circuits → greater risk of drug abuse in adult life
damaged brain regions: basal ganglia, cerebellum, thalamus, pons, hippocampus
myelin loss → cognitive decline, slower processing, cerebellar ataxia (slowed neuronal transmission)

35
Q

targeting myelinated neurons

A

myelin is made of lipids = accumulation of inhalants

chronic toluene abuser → decreased brain volume and exaggerated sulci

36
Q

2,5-hexanedione

A

metabolite of hexane
penetrates neuronal axons and cross-links neuron cytoskeletal components
more components (targets) found in long peripheral neurons (ex. motoneurons) → more susceptible to damaging effects